Qiang Tian, MD, PhD
Qiang Tian, MD, PhD, serves as Scientific Director of the P4 Medicine Institute overseeing scientific and academic affairs of the institute. Dr. Tian is a senior investigator and head of the Cancer & Stem Cell Group at the Institute for Systems Biology. He has also held affiliate and visiting professorships at Chinese Academy of Medical Sciences, Chinese Academy of Sciences, and University of Washington Medical School.
With a career path traversing clinical medicine, molecular genetics, and systems biology, Dr. Tian is primarily interested in applying the powerful systems approach with the enabling genomics, proteomics, and single cell analysis technologies to address some of the most pressing issues pertaining to human health: cancer and stem cell biology, immunity, and disease biomarker discovery. He directs an interdisciplinary team focusing on translational efforts to dissect clonal origin of cancer heterogeneity and the underlying genomic landscape and molecular mechanism contributing to tumorigenesis and therapeutic responses. Dr. Tian has led the development of gene signature panels for cancer patient stratification, and has elucidated protein interaction networks and relevant phosphorylation events in the Wnt signaling pathway. He also contributed to the definition and molecular characterization of several Th cell subsets. He publishes extensively in high impact journals, and is an inventor of three U.S. patents. Dr. Tian collegially reaches out to global medical communities to promote Systems Medicine and P4 Healthcare. His academic efforts have been continuously supported by federal and foundational grants, including a highly competitive R01 award addressing NCI’s provocative questions. Dr. Tian has served as an expert grant reviewer for funding agencies around the world (US, UK, France, Switzerland, EU, and China), co-founded two US biotech companies, and was Secretary General and President-elect for the Seattle Chinese Biomedical Association.